Clinical trials
Breast clinical trials
Below are recruiting breast clinical trials, each written for real people, not researchers. We’re tracking 2,679 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07195058Recruiting
Trauma-Informed Care for First-Time Moms
This study looks at a new way of providing pregnancy care that is sensitive to past trauma. If you are a first-time mother who speaks Spanish, this trial may help understand how to make pregnancy care safer and more comforting for you.
Buenos Aires, Buenos Aires F.D.Ages 18–45 - NCT07198581Recruiting
Using AI to manage chemotherapy side effects
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
IncheonAges 18 years+ - NCT07201194Recruiting
Acupuncture for chemotherapy nausea
This trial tests if acupuncture can help reduce nausea in people who still feel sick despite taking their regular anti-nausea medication during chemotherapy.
VejleAges 18 years+ - NCT07203378RecruitingPhase 2
Exercise program to boost energy on Enhertu
This trial tests if a guided exercise program can help reduce fatigue and improve energy for people with breast cancer who are taking the drug Enhertu. You would do both aerobic and resistance exercises as part of the study.
Salt Lake City, UtahAges 18 years+ - NCT07213791RecruitingPhase 1
Study of a new drug for FAP-positive cancers
This trial tests a new drug (LY4337713) for cancers that have a specific protein called FAP on their surface. It may be an option for people whose cancer has continued to grow after standard treatments.
Newport Beach, CaliforniaAges 18 years+ - NCT07216105RecruitingPhase 1
FT836 immune cell therapy for advanced solid tumors
This study tests a new immune cell therapy called FT836, given alone or with chemotherapy or other antibodies, for people with advanced solid tumors that have not responded to previous treatments. The goal is to see if it is safe and helps shrink or control tumors.
La Jolla, CaliforniaAges 18 years+ - NCT07225114RecruitingPhase 2
Better ultrasound imaging with contrast before biopsy
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
Chapel Hill, North CarolinaAges 18 years+ - NCT07233863Recruiting
Lymphovenous bypass for preventing lymphedema in breast cancer
This trial tests a surgery (lymphovenous bypass) to prevent or slow down lymphedema (arm swelling) in breast cancer patients who have already had lymph nodes removed. It may help those with early-stage lymphedema who haven't tried physical therapy yet.
Jakarta, Jakarta Special Capital RegionAges 18 years+ - NCT07236177RecruitingEarly Phase 1
Enzyme test for early breast, lung, or pancreatic cancer
This study tests a new blood test that measures enzyme activity to detect localized cancer. It is for people with newly diagnosed, untreated breast, lung, or pancreatic cancer, as well as healthy volunteers.
PoitiersAges 18 years+ - NCT07238088Recruiting
Mammogram checkup and guidance for Puerto Rico
This trial helps women aged 40-74 in certain areas of Puerto Rico who are overdue for a mammogram. It offers counseling and resources to get screened for breast cancer.
San JuanAges 40–74 - NCT07250386RecruitingPhase 1
CEA-targeted CAR-T therapy for advanced solid tumors
This trial tests a new CAR-T cell therapy that targets CEA, a protein found on certain cancer cells. It's for people with advanced solid tumors like lung or breast cancer who have not responded to other treatments.
Hangzhou, ZhejiangAges 18 years+ - NCT05183126RecruitingPhase 4
Paclitaxel dose study using a 1-hour muscle-area infusion
This trial studies how paclitaxel (a chemotherapy medicine) behaves in the body when given by a specific 1-hour infusion approach. It may help refine dosing for people with cancer using measurements from scans, and it includes a medicine schedule you must match.
Ann Arbor, MichiganAges 18 years+ - NCT03412877RecruitingPhase 2
Personalized immune-cell therapy for advanced metastatic cancers
This trial tests a personalized cell therapy made from your own immune cells, changed to recognize “neoantigens” on cancer cells. It’s designed for people with metastatic (advanced spread) solid cancers or certain other cancers who have tried standard treatments but cancer is still growing.
Bethesda, MarylandAges 18–72 - NCT07059884Recruiting
Exercise program to help people with cancer stay active
This trial tests a distance-based exercise program designed to help people on chemotherapy maintain their physical function and prevent disability. It is for patients with certain cancers who are working full-time and can participate in moderate physical activity.
Dublin, CaliforniaAges 18 years+ - NCT07252687Recruiting
How Gender-Affirming Care Affects Breast Perception in Trans Men
This study looks at how gender-affirming treatments (like hormone therapy or chest surgery) affect how trans men feel about their chest. It aims to help understand the best timing for these treatments.
InnsbruckAges 16 years+ - NCT07253987Recruiting
Cancer Survivors Program for Breast or Prostate Cancer
This study offers a program to help people who have completed their main treatment for early-stage breast or prostate cancer. It focuses on follow-up and support during survivorship, and you are still eligible if you are on certain maintenance therapies like hormone therapy.
BrnoAges 18 years+ - NCT07256119Recruiting
Can a supplement help ease radiation skin burns?
This study tests whether taking an antioxidant called alpha lipoic acid can reduce skin irritation caused by radiation therapy in women with early-stage breast cancer. If you qualify, you would receive the supplement during your radiation treatment to see if it helps protect your skin.
ZagazigAges 18–75 - NCT07257679RecruitingPhase 4
Gentle touch for arm swelling after breast cancer surgery
This study tests a gentle hand-on technique (called Gentle Touch) to see if it helps reduce arm swelling in women who developed lymphedema after breast cancer surgery. It may offer a new way to manage this side effect.
Roma, RMAges 30–75 - NCT07257770Recruiting
Gel for breast pain after surgery
This trial tests a soothing gel you apply to your breast to see if it relieves pain after surgery. It might help if you still feel discomfort around your surgical wound.
RomaAges 18–70 - NCT07260591RecruitingPhase 1
VSV-02 for advanced solid tumors that need new options
This trial tests an experimental virus therapy called VSV-02 for people with advanced solid tumors that have not responded to standard treatments. The treatment is given directly into a tumor, aiming to attack cancer from the inside.
Xinxiang, HenanAges 18 years+ - NCT07268846Recruiting
Prebiotic supplement before colorectal cancer surgery
This trial tests if taking a postbiotic supplement before surgery for colorectal cancer can improve recovery. It may help patients with adenocarcinoma of the large intestine prepare for their operation.
São Paulo, São PauloAges 18 years+ - NCT07270679Recruiting
Genetic markers for ovarian damage after chemo
This study is looking for genetic markers that may help predict how chemotherapy affects the ovaries. It's for women who had breast cancer or lymphoma, froze their ovarian tissue before treatment, and finished that treatment at least 6 months ago.
Bologna, BolognaAges 18–38 - NCT07281339Recruiting
Hypnobreastfeeding education for high-risk pregnancy
This trial tests if hypnosis-enhanced breastfeeding education helps high-risk pregnant women who haven't given birth before. It may improve breastfeeding success and reduce stress.
AmasyaAges Any age - NCT07283692RecruitingPhase 2
New drug combo for triple-negative breast cancer before surgery
This trial tests a new drug, serplulimab, combined with standard chemotherapy (paclitaxel and carboplatin) given before surgery for triple-negative breast cancer. The goal is to see if this combination can shrink tumors more effectively.
ShanghaiAges 18–70
Hear when a new Breast trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast?
- Yes. Clin2 currently lists 2,679 recruiting breast studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.